Intensivmedizinische Aspekte bei hämatologischen und onkologischen Erkrankungen

Kernaussagen

• Intensivmediziner sind häufig mit der Versorgung kritisch kranker Krebspatienten konfrontiert. Die Kurz- und Langzeitprognose der Betroffenen hat sich innerhalb der vergangenen Jahrzehnte erheblich verbessert.

• Die hämatologische und onkologische Prognose hat keinen wesentlichen Einfluss auf das Überleben des Intensivaufenthalts. Umgekehrt hat auch ein überlebter Aufenthalt auf der Intensivstation keinen Einfluss auf das Langzeitüberleben bzw. den hämatologischen oder onkologischen Verlauf.

• Für eine sinnvolle Umsetzung der verfügbaren evidenzbasierten Kriterien für die Aufnahme auf die Intensivstation, eine angemessene Therapiezielfindung und die Bewältigung der häufigen, vielfältigen und spezifischen Problemstellungen bedarf es eines soliden hämatologischen und onkologischen Grundwissens der Intensivmediziner sowie einer engen Kooperation mit den behandelnden Hämatologen und Onkologen.

• Literatur

• 1 Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007; 25: 3274-3280
• 2 Mariotto AB, Yabroff KR, Shao Y et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103: 117-128
• 3 Taccone FS, Artigas AA, Sprung CL et al. Characteristics and outcomes of cancer patients in European ICUs. Crit Care 2009; 13: R15
• 4 Azoulay E, Soares M, Darmon M et al. Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 2011; 1: 5
• 5 Puxty K, McLoone P, Quasim T et al. Survival in solid cancer patients following intensive care unit admission. Intensive Care Med 2014; 40: 1409-1428
• 6 Azoulay E, Mokart D, Pene F et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium – a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 2013; 31: 2810-2818
• 7 Zuber B, Tran TC, Aegerter P et al. Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 2012; 40: 55-62
• 8 Lecuyer L, Chevret S, Guidet B et al. Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 2008; 32: 748-754
• 9 Pene F, Percheron S, Lemiale V et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 2008; 36: 690-696
• 10 Vandijck DM, Benoit DD, Depuydt PO et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008; 34: 847-855
• 11 Gruson D, Vargas F, Hilbert G et al. Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia. Intensive Care Med 2004; 30: 965-971
• 12 Azoulay E, Lemiale V, Mokart D et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 2014; 40: 1106-1114
• 13 Chaoui D, Legrand O, Roche N et al. Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 2004; 18: 670-675
• 14 Legrand M, Max A, Peigne V et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 43-49
• 15 Ferrer R, Artigas A, Levy MM et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008; 299: 2294-2303
• 16 Staudinger T, Stoiser B, Mullner M et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28: 1322-1328
• 17 Oeyen SG, Benoit DD, Annemans L et al. Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study. Intensive Care Med 2013; 39: 889-898
• 18 Massion PB, Dive AM, Doyen C et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002; 30: 2260-2270
• 19 Schellongowski P, Staudinger T, Kundi M et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 2011; 96: 231-237
• 20 Schellongowski P, Wohlfahrth P, Michael K et al. Incidence of Intensive Care Unit Admission, Outcome, and Post Intensive Care Survival in Patients with Acute Lymphocytic Leukemia or Burkitt Lymphoma (ASH Congress Abstract). Blood 2014; 124: 2633
• 21 Wohlfarth P, Carlström A, Staudinger T et al. Incidence of Intensive Care Unit Admission, Outcome, and Post Intensive Care Survival in Patients with Diffuse Large B-Cell Lymphoma. Leuk Lymphoma 2015; DOI
• 22 Azoulay E, Recher C, Alberti C et al. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 1999; 25: 1395-1401
• 23 Wohlfarth P, Ullrich R, Staudinger T et al. Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care 2014; 18: R20
• 24 Rabbat A, Chaoui D, Montani D et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol 2005; 129: 350-357
• 25 Roze des Ordons AL, Chan K, Mirza I et al. Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study. BMC Cancer 2010; 10: 516
• 26 Azoulay E, Kouatchet A, Jaber S et al. Noninvasive mechanical ventilation in patients having declined tracheal intubation. Intensive Care Med 2013; 39: 292-301
• 27 van Vliet M, van den Boogaard M, Donnelly JP et al. Long-Term Health Related Quality of Life following Intensive Care during Treatment for Haematological Malignancies. PLoS One 2014; 9: e87779
• 28 Darmon M, Azoulay E, Alberti C et al. Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 2002; 28: 1775-1780
• 29 Kress JP, Christenson J, Pohlman AS et al. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160: 1957-1961
• 30 Lecuyer L, Chevret S, Thiery G et al. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808-814
• 31 Zapol WM, Snider MT, Hill JD et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979; 242: 2193-2196
• 32 Kompanje EJ, Piers RD, Benoit DD. Causes and consequences of disproportionate care in intensive Care Med. Curr Opin Crit Care 2013; 19: 630-635
• 33 Thiery G, Azoulay E, Darmon M et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406-4413
• 34 Hanzelka KM, Yeung SC, Chisholm G et al. Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center. Support Care Cancer 2013; 21: 727-734
• 35 Mokart D, Lambert J, Schnell D et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 2013; 54: 1724-1729
• 36 Mokart D, Saillard C, Sannini A et al. Neutropenic cancer patients with severe sepsis: need for antibiotics in the first hour. Intensive Care Med 2014; 40: 1173-1174
• 37 Squadrone V, Massaia M, Bruno B et al. Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med 2010; 36: 1666-1674
• 38 Lengline E, Raffoux E, Lemiale V et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 2012; 53: 1352-1359
• 39 Schellongowski P. Cancer patients in the intensive care unit. Goals of therapy, ethics, and palliation. Med Klin Intensivmed Notfmed 2013; 108: 203-208
• 40 accessed at https://www.capc.org/ipal/ipal-icu/
• 41 Hilbert G, Gruson D, Vargas F et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481-487
• 42 Azoulay E, Alberti C, Bornstain C et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519-525
• 43 Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 2006; 32: 808-822
• 44 Azoulay E, Mokart D, Lambert J et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 1038-1046
• 45 Antonelli M, Conti G, Bufi M et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA 2000; 283: 235-241
• 46 Lemiale V, Resche-Rigon M, Mokart D et al. Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en reanimation onco-hematologique (Grrr-OH) study. Ann Intensive Care 2015; 5: 28
• 47 Lemiale V, Mokart D, Resche-Rigon M et al. Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial. JAMA 2015; 314: 1711-1719
• 48 Frat JP, Thille AW, Mercat A et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372: 2185-2196
• 49 Adda M, Coquet I, Darmon M et al. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 2008; 36: 2766-2772
• 50 Amado-Rodríguez L, Bernal T, López-Alonso I et al. Impact of Initial Ventilatory Strategy in Hematological Patients with Acute Respiratory Failure: a Systematic Review and Meta-Analysis. Crit Care Med 2016; 44: 1406-1413
• 51 Soares M, Salluh JI, Azoulay E. Noninvasive ventilation in patients with malignancies and hypoxemic acute respiratory failure: a still pending question. J Crit Care 2010; 25: 37-38
• 52 Thirumala R, Ramaswamy M, Chawla S. Diagnosis and management of infectious complications in critically ill patients with cancer. Crit Care Clin 2010; 26: 59-91
• 53 Azoulay E, Darmon E. Acute respiratory distress syndrome during neutropenia recovery. Crit Care 2010; 14: 114
• 54 Balsat M, Xhaard A, Lengline E et al. Worsening of Respiratory Status during Neutropenia Recovery in Noncritically Ill Hematological Patients: Results of a Prospective Multicenter Study. Respiration 2015; 90: 229-234
• 55 Penack O, Becker C, Buchheidt D et al. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol 2014; 93: 1083-1095
• 56 Maschmeyer G, Carratala J, Buchheidt D et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 2015; 26: 21-33
• 57 Wohlfarth P, Staudinger T, Sperr WR et al. Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol 2014; 93: 1629-1636
• 58 Benoit DD, Depuydt PO, Vandewoude KH et al. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 2006; 32: 93-99
• 59 Song JU, Suh GY, Chung MP et al. Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer 2011; 19: 491-495
• 60 Cairo MS, Coiffier B, Reiter A et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010; 149: 578-586
• 61 Schellongowski P, Staudinger T. Leukostasis and tumor lysis: important complications of hyperleukocytosis. Internist (Berl) 2013; 54: 1051-1060
• 62 Coiffier B, Altman A, Pui CH et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008; 26: 2767-2778
• 63 Azoulay E, Canet E, Raffoux E et al. Dexamethasone in patients with acute lung injury from acute monocytic leukaemia. Eur Respir J 2012; 39: 648-653
• 64 Sanz MA, Grimwade D, Tallman MS et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009; 113: 1875-1891
• 65 Szczepiorkowski ZM, Winters JL, Bandarenko N et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25: 83-177
• 66 Lengline E, Chevret S, Moreau AS et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2015; 50: 840-845
• 67 Afessa B, Azoulay E. Critical care of the hematopoietic stem cell transplant recipient. Crit Care Clin 2010; 26: 133-150
• 68 von Bergwelt-Baildon M, Holtick U, Hallek MJ et al. Hematopoietic stem cell transplantation: bone marrow and blood stem cells. Internist (Berl) 2014; 55: 1306-1312